Close

Professor David Heymann

BA MD DTM&H

Professor

Room
G82

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
+44 791 962 6171

David Heymann holds a BA in general science from Penn State University, an M.D from Wake Forest School of Medicine, and a DTM&H from London School of Hygiene and Tropical Medicine (LSHTM).  He is currently Professor of Infectious Disease Epidemiology at LSHTM and Head of the Centre on Global Health Security at Chatham House, London. From 2012 to March 2017 he was chairman of Public Health England

For 22 years Heymann was based at the World Health Organization (WHO) in Geneva on secondment from the Centers for Disease Control and Prevention (CDC) during which time he rose from Chief of Research of the Global Programme on AIDS to Founding Director of the Programme on Emerging and other Communicable Diseases.  He then was named Executive Director of the Communicable Diseases Cluster, a position from which he headed the global response to SARS, and finally was named Assistant Director for Health Security and the Director General’s Representative for Polio Eradication.

Before joining WHO Heymann was based for 13 years in sub-Saharan Africa on assignment from CDC where he worked Cameroon, Cote d’Ivoire, DRC and Malawi.  During this period he participated in the response to the first, second and third outbreaks of Ebola hemorrhagic fever in DRC, investigated human monkeypox outbreaks throughout central and western Africa, and supported ministries of health in field research aimed at better control of malaria, measles, tuberculosis and other infectious diseases. Prior to joining CDC Heymann worked in India for two years as a medical epidemiologist in the WHO smallpox eradication programme.

Heymann is an elected fellow of the Institute of Medicine of the National Academies (US) and the Academy of Medical Sciences (UK), and has received seven different public health awards, including the Heinz Award on the Human Condition, that have provided funding for the establishment of an on-going mentorship programme at the International Association of Public Health Institutes (IANPHI).   

Heymann has published over 200 peer reviewed articles, commentaries and book chapters, and is the editor of the Control of Communicable Diseases Manual, a major global reference for public health and health protection. In 2009 he was appointed an honorary Commander of the Most Excellent Order of the British Empire (CBE) for service to global public health.

Affiliations

Department of Infectious Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

Teaching responsibilities at LSHTM range from the epidemiology and control of communicable diseases to the evaluation/use of vaccines and global health/policy. Heymann also participates in various lecture series and the executive leadership programmes.

Research

Research Area
Infectious disease policy
Discipline
Epidemiology
Disease and Health Conditions
Infectious disease
Region
East Asia & Pacific (all income levels)
Sub-Saharan Africa (all income levels)
World

Selected Publications

Calling for a COVID-19 One Health Research Coalition.
Amuasi JH; Walzer C; Heymann D; Carabin H; Huong LT; Haines A; Winkler AS
2020
Lancet (London, England)
COVID-19: towards controlling of a pandemic.
Bedford J; Enria D; Giesecke J; Heymann DL; Ihekweazu C; Kobinger G; Lane HC; Memish Z; Oh M-D; Sall AA
2020
Lancet (London, England)
Digital technologies in the public-health response to COVID-19.
Budd J; Miller BS; Manning EM; Lampos V; Zhuang M; Edelstein M; Rees G; Emery VC; Stevens MM; Keegan N
2020
Nature medicine
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
Han E; Tan MMJ; Turk E; Sridhar D; Leung GM; Shibuya K; Asgari N; Oh J; García-Basteiro AL; Hanefeld J
2020
Lancet (London, England)
Successful smallpox eradication: what can we learn to control COVID-19?
Heymann DL; Wilder-Smith A
2020
Journal of travel medicine
Epidemic preparedness in urban settings: new challenges and opportunities.
Lee VJ; Ho M; Kai CW; Aguilera X; Heymann D; Wilder-Smith A
2020
The Lancet Infectious Diseases
Serology testing in the COVID-19 pandemic response.
Peeling RW; Wedderburn CJ; Garcia PJ; Boeras D; Fongwen N; Nkengasong J; Sall A; Tanuri A; Heymann DL
2020
The Lancet. Infectious diseases
Human monkeypox - After 40 years, an unintended consequence of smallpox eradication.
Simpson K; Heymann D; Brown CS; Edmunds WJ; Elsgaard J; Fine P; Hochrein H; Hoff NA; Green A; Ihekweazu C
2020
Vaccine
See more Publications